Healthcare -
Biotechnology - NASDAQ - US
$ 2.75
2.23 %
$ 132 M
Market Cap
-1.99
P/E
SAVA - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity SAVA - Cassava Sciences, Inc.
152 M
LAST VALUE
-24.60%
2 YEAR CAGR
49.75%
5 YEAR CAGR
11.71%
10 YEAR CAGR